SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : QLT PhotoTherapeutics (QLTI)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Edward W. Richmond who wrote (1146)12/22/2000 10:08:08 AM
From: Ian@SI   of 1321
 
Ed,

Agree that tax loss selling will end: Today in Canada and boxing day in the US, if it hasn't already ended.

There are relatively inexpensive, effective alternatives for most skin cancers. Thus I wouldn't expect the skin cancer PDT to have anywhere near the growth trajectory that Visudyne will provide. I do hope that I'm wrong however; and that the benefits of PDT cause it to displace the status quo.

Best wishes,
Ian.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News